Baker Brothers Advisors - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 160 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,019,042
-53.3%
190,476
-70.6%
0.04%
-38.6%
Q3 2021$12,894,000
+15.2%
647,3130.0%0.06%
+16.3%
Q2 2021$11,192,000
-12.8%
647,3130.0%0.05%
-12.5%
Q1 2021$12,830,000
+13.5%
647,3130.0%0.06%
+30.2%
Q4 2020$11,302,000
+6.1%
647,313
+17.1%
0.04%0.0%
Q3 2020$10,656,000
-6.1%
553,009
-5.2%
0.04%
-14.0%
Q2 2020$11,352,000
+39.0%
583,3330.0%0.05%0.0%
Q1 2020$8,167,000
-0.1%
583,333
+75.0%
0.05%
+16.3%
Q4 2019$8,173,000
+143.8%
333,3330.0%0.04%
+87.0%
Q3 2019$3,353,000333,3330.02%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 3,566,912$62,278,0004.80%
RiverVest Venture Management LLC 1,921,118$33,543,0003.68%
Burrage Capital Management LLC 161,628$2,822,0002.15%
AIGH Capital Management LLC 274,583$4,794,0001.95%
NEA Management Company, LLC 4,187,801$73,119,0001.93%
Novo Holdings A/S 2,445,147$42,692,0001.83%
Sio Capital Management, LLC 494,743$8,638,0001.77%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,448,912$60,218,0001.19%
Rock Springs Capital Management LP 1,496,525$26,129,0000.55%
Prosight Management, LP 60,250$1,052,0000.49%
View complete list of MIRUM PHARMACEUTICALS INC shareholders